0001415889-22-002441.txt : 20220303 0001415889-22-002441.hdr.sgml : 20220303 20220303200809 ACCESSION NUMBER: 0001415889-22-002441 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220301 FILED AS OF DATE: 20220303 DATE AS OF CHANGE: 20220303 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Carter Percy H. CENTRAL INDEX KEY: 0001863024 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37359 FILM NUMBER: 22711578 MAIL ADDRESS: STREET 1: C/O BLUEPRINT MEDICINES CORPORATION STREET 2: 45 SIDNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Blueprint Medicines Corp CENTRAL INDEX KEY: 0001597264 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 45 SIDNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 617-374-7580 MAIL ADDRESS: STREET 1: 45 SIDNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 4 1 form4-03032022_050354.xml X0306 4 2022-03-01 0001597264 Blueprint Medicines Corp BPMC 0001863024 Carter Percy H. C/O BLUEPRINT MEDICINES CORPORATION 45 SIDNEY STREET CAMBRIDGE MA 02139 false true false false CHIEF SCIENTIFIC OFFICER Common Stock 2022-03-01 4 A 0 8750 0 A 30593 D Stock Option (Right to Buy) 61.31 2022-03-01 4 A 0 17500 0 A 2032-03-01 Common Stock 17500 17500 D The reported transaction involved the Reporting Person's receipt of a grant of 8,750 restricted stock units under the Issuer's 2015 Stock Option and Incentive Plan. This option vests with respect to 1/48th of the shares underlying the option on April 1, 2022 and as to an additional 1/48th of the shares underlying the option each month thereafter. /s/ Ariel Hurley, Attorney-in-Fact 2022-03-03